Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly To Present At Leerink Partners Global Healthcare Conference

[PR Newswire] – INDIANAPOLIS, Jan. 27, 2016 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 10, 2016. Derica Rice, Lilly’s executive … Read more on this. Eli Lilly and Company (LLY) , with a current value of $86.51B, opened this morning at $81.61. Looking at today’s trading action, the company’s one day range from $81.18 to $83.25 and has traded between $68.31 and $92.85 over the past 12 months. LLY shares are currently priced at 23.90x this year’s forecasted earnings, which makes them relatively expensive compared to the industry ’s -1.49x earnings multiple for the same period. And for income investors, the company pays shareholders $2.04 per share annually in dividends, yielding 2.47%. According to a consensus of 19 analysts, the earnings estimate of $0.78 per share would be $0.03 better than the year-ago quarter and a $0.00 sequential decrease. The full-year EPS estimate is $3.43 which would be a $0.65 improvement than last year’s full-year earnings. The quarterly earnings estimate is predicated on a consensus revenue forecast of $5.32 Billion. If reported, that would be a 3.91% increase over the year-ago quarter. More recently, BMO Capital Markets upgraded LLY from Market Perform to Outperform (Nov 13, 2015). Previously, Credit Suisse upgraded LLY from Neutral to Outperform. The average price target for LLY shares is $99.50, which is 21.92% above where the stock opened this morning. See more in (NYSE:LLY) Similar Articles: Company Update: Baxter International Inc (NYSE:BAX) – Baxter to Present at The Leerink Partners 5th Annual Global Healthcare Conference Stock Update (NYSE:LLY): Lilly to Present at J.P. Morgan Healthcare Conference Market Update (NYSE:LLY): Lilly to Participate in Morgan Stanley Global Healthcare Conference